Statistics show that ninety percent of the world’s 33 million HIV/AIDS cases are in Africa, Latin America, and Asia. These areas are known to be much more deficient and therefore can not afford the drug to help fight AIDS. The quandary for the drug companies is how to make these drugs more inexpensive. These drugs are very much needed. 8 percent of the 38 million people in South Africa are infected with the AIDS virus.
Western drug companies face issues of social responsibility in both short and long terms. Their short term responsibility is to deal with the pressure they are receiving from health organizations around the world, global competitio